VALORISATION HSJ, LIMITED PARTNERSHIP;THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
发明人:
Christopher CAIRO,Alexey PCHEJETSKI,Tianlin GUO
申请号:
US16616426
公开号:
US20200239512A1
申请日:
2018.05.25
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a method of preventing or treating atherosclerosis or a symptom thereof comprising administering to a subject in need thereof a specific inhibitor of neuraminidase 1 (neu1); neuraminidase 3 (neu3); or a bispecific inhibitor of neu1 or neu3 of formula I; (I) and a compound of formula I.